유럽 및 중동(EME)의 혈액 가스 및 전해질 분석기 시장 : 제품별, 모달리티별, 최종 사용자별, 지역별

Eme Blood Gas And Electrolyte Analyzers Market is estimated to be valued at USD 187.2 Mn in 2026 and is expected to reach USD 272.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033.

Blood gas analysis is performed for critically ill patients suffering from respiratory or metabolic disorders. Blood gas analysis includes measurement of the amount of oxygen, carbon dioxide, and the acidity of pH in the blood as well as concentrations of other parameters such as creatinine, electrolytes, glucose, hemoglobin, and lactate. Blood gas analyzers use electrodes to determine pH, partial pressure of carbon dioxide, and amount of oxygen in the blood. Imbalances in oxygen, carbon dioxide, and pH levels in the blood can indicate the presence of certain medical conditions such as heart failure, hemorrhage, kidney failure, chemical poisoning, uncontrolled diabetes, or drug overdose. Blood gas and electrolyte analyzer include blood gas measuring items (PH, PCO2, and PO2). Electrolyte measuring items (Na+, K+, CH, Ca2+). It is used to detect partial pressure of Carbon Dioxide (PCO2), and partial pressure of Oxygen (PO2) value. Blood gas and electrolyte analyzer is considered the most important tool for diagnosis in patients with either respiratory or metabolic abnormalities. Blood conservation is an important initiative in every clinical diagnostic lab or critical care facility. Therefore, a highly accurate blood gas analyzer can streamline work processes and reduce errors with minimum maintenance. Most blood gas analyzers offer automatic sample mixing and easy sample aspiration with an intuitive user interface built-in and automatic QC for accuracy and regulatory compliance. The high prevalence of chronic diseases and the increasing geriatric population is expected to fuel the growth of the EME blood gas and electrolyte analyzers market over the forecast period.

Market Dynamics

Increasing rates of geriatrics and chronic diseases including cancer and cardiovascular diseases (CVD) is expected to propel the growth of the EME blood gas and electrolyte analyzers market over the forecast period. For instance, in September 2022, according to World Health Organization (WHO), cardiovascular diseases account for most Noncommunicable diseases (NCD) deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million including kidney disease deaths caused by diabetes).

Key features of the study:

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the EME blood gas and electrolyte analyzers market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study are Abbott, Medica Corporation, Nova Biomedical, Radiometer Medical ApS, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, EKF Diagnostics, ERBA Diagnostics Mannheim GmbH, Inspira-Technologies OXY B.H.N. LTD., and Werfen.
• Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• EME blood gas and electrolyte analyzers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the EME blood gas and electrolyte analyzers market

Detailed Segmentation:

• EME Blood Gas and Electrolyte Analyzers Market, By Product Type (Revenue, USD Mn, 2021 - 2033)
• Blood Gas Analyzers
• Electrolyte Analyzers
• Combination Analyzers
• Consumables
• EME Blood Gas and Electrolyte Analyzers Market, By Modality:
• Laboratory Analyzers
• Benchtop Analyzers
• Portable Analyzers
• EME Blood Gas and Electrolyte Analyzers Market, By End User:
• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers
• Clinics
• EME Blood Gas and Electrolyte Analyzers Market, By Region (Revenue, USD Mn, 2021 - 2033)
• Europe
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Nordics
  • Denmark
  • Finland
  • Iceland
  • Norway
  • Sweden
  • Russia
  • Rest of Europe
• Middle East
  • Saudi Arabia
  • UAE
  • Turkey
  • GCC
  • Israel
  • Rest of Middle East
• Company Profiles
• Abbott
• Medica Corporation
• Nova Biomedical
• Radiometer Medical ApS
• Hoffmann-La Roche Ltd
• Siemens Healthcare GmbH
• EKF Diagnostics
• ERBA Diagnostics Mannheim GmbH
• Inspira-Technologies OXY B.H.N. LTD.
• Werfen

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Modality
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Attractiveness Analysis
  • Market Opportunities
  • Merger, Acquisition, Collaborations
  • Funding and Investment
  • Future Prospective
  • Regulatory Guideline and Compliances
  • Key Developments
  • PEST Analysis
  • PORTER's Analysis

4. EME Blood Gas and Electrolyte Analyzers Market, By Product Type, 2021 - 2033, (US$ Million)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segment Trends
• Blood Gas Analyzers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
• Electrolyte Analyzers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
• Combination Analyzers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
• Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

5. EME Blood Gas and Electrolyte Analyzers Market, By Modality, 2021 - 2033, (US$ Million)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segments Trends
• Laboratory Analyzers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
• Benchtop Analyzers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
• Portable Analyzers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

6. EME Blood Gas and Electrolyte Analyzers Market, By End User, 2021 - 2033, (US$ Million)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022-2033
  • Segments Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

7. EME Blood Gas and Electrolyte Analyzers Market, By Region, 2021 - 2033, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Region, 2022-2033
  • Regional Trends
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Nordics
    • Denmark
    • Finland
    • Iceland
    • Norway
    • Sweden
    • Russia
    • Rest of Europe
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
    • Saudi Arabia
    • UAE
    • Turkey
    • GCC
    • Israel
    • Rest of Middle East

8. Competitive Landscape

• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Medica Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Nova Biomedical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Radiometer Medical ApS
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• F.Hoffmann-La Roche Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Siemens Healthcare GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• EKF Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ERBA Diagnostics Mannheim GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Inspira-Technologies OXY B.H.N. LTD
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Werfen
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

9. Section

• Research Methodology
• About Us